Schedule 13G ownership disclosure

KITE PHARMA INC COM

Security class unavailable · CUSIP: 49803L109

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,207,203
Percent of class
4.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-16-000095
Form type
SC 13G/A
Filer
Kite Pharma, Inc.
CIK
CIK 1510580
Filed
Feb 16, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub